表纸
市场调查报告书

毛囊性血癌:全球临床实验趋势

Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品编码 233619
出版日期 内容资讯 英文 123 Pages
订单完成后即时交付
价格
毛囊性血癌:全球临床实验趋势 Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017
出版日期: 2017年08月31日内容资讯: 英文 123 Pages
简介

本报告提供全球毛囊性血癌治疗药临床实验上之相关调查,提供您各地区,各阶段,各进展状况之临床实验趋势,临床实验主要的参与企业和有潜力药剂资讯,及最新临床实验相关新闻等资料。

本报告概要

各地区的临床实验情形

  • 各国临床实验数量和平均实验人数
    • 亚太地区主要国家的临床实验数量
    • 欧洲主要5国的临床实验数量
    • 北美主要国家的临床实验数量
    • 中东·非洲主要国家的临床实验数量
    • 中南美主要国家的临床实验数量

G7各国临床实验数量:癌症治疗药临床实验上毛囊性血癌的比例

G7各国的各阶段临床实验数量

G7各国临床实验数量:各进展状况

E7各国临床实验数量:癌症治疗药临床实验上毛囊性血癌的比例

E7各国的各阶段临床实验数量

各阶段临床实验数量

  • 进行中的临床实验:各阶段

各进展状况临床实验数量

临床实验的目标达成情形

一定期间所采用的实验对像

赞助商类别的临床实验数量

有潜力的赞助商

毛囊性血癌治疗药临床实验主要的参与企业

有潜力的药剂

临床实验简介概要

附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDHC4537CTIDB

GlobalData's clinical trial report, "Hairy Cell Leukemia Global Clinical Trials Review, H2, 2017" provides an overview of Hairy Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hairy Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Hairy Cell Leukemia to Oncology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Hairy Cell Leukemia to Oncology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Hairy Cell Leukemia Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Clinical Trial Profile Snapshots 28

Appendix 120

  • Abbreviations 120
  • Definitions 120
  • Research Methodology 121
  • Secondary Research 121
  • About GlobalData 122
  • Contact Us 122
  • Disclaimer 122
  • Source 123

List of Tables

List of Tables

  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Hairy Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Hairy Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Hairy Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2017* 17
  • Hairy Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Phase, 2017* 19
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Hairy Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures

List of Figures

  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Hairy Cell Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
  • Proportion of Hairy Cell Leukemia to Oncology Clinical Trials, G7 Countries (%), 2017* 14
  • Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Hairy Cell Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Hairy Cell Leukemia to Oncology Clinical Trials, E7 Countries (%), 2017* 17
  • Hairy Cell Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
  • Hairy Cell Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
  • Hairy Cell Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
  • Hairy Cell Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
  • GlobalData Methodology 121